But the data also revealed something that gets less attention: the gap in discontinuation rates between dose groups
Many of our patients from San Ramon, Danville, Dublin, and Pleasanton come to us managing conditions like PCOS and semaglutide for weight loss, weight loss after menopause, GLP-1 for insulin resistance, GLP-1 for prediabetes, semaglutide for cardiovascular health, GLP-1 for metabolic syndrome, semaglutide for fatty liver (MASH), GLP-1 for sleep apnea, and hormone-related weight gain and hormonal obesity all conditions where GLP-1 therapy can address multiple health issues simultaneously
Many companies that require one offer free virtual consultations, with eligible patients potentially receiving approval within 24 hours
one large survey found that 1.3% of lifetime psychedelic users reported receiving a formal HPPD diagnosis from a medical professional [116]
this includes 63% of firms with 5,000 or more workers
B., Jean, P